A Study of the Effect of Lenalidamide on Complex Regional Pain Syndrome Type 1
This study has been completed.
Information provided by:
First received: September 12, 2005
Last updated: March 22, 2011
Last verified: March 2011
The purpose of this study is to determine if lenalidomide is a safe and effective treatment for complex regional pain syndrome type 1 (CRPS).
|Study Design:||Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Crossover Assignment
Primary Purpose: Treatment
|Official Title:||Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Lenalidamide in the Treatment of Complex Regional Pain Syndrome Type1|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Mayo Clinic:
Contacts and Locations